
Frequent readers of The Health Care Blog have probably noticed Xerox’s name around more and more often – we partner with THCB to provide content and cover events. Was it unexpected at first? Are you beginning to understand why Xerox is represented in an outlet where conversations are dedicated to discussing healthcare hot topics?
We hope so. This week, our CEO, Ursula Burns spoke at the World Health Care Congress, and I’m sure that some of the attendees were scratching their heads about that as well. To be clear for anyone still wondering, healthcare is a primary area of focus for Xerox. Today, Xerox touches the lives of nearly one in every three insured individuals in the U.S. as the largest provider to manage all documents and business process needs within healthcare organizations.
One of our priorities is to simplifying how work gets done for healthcare professionals now and in the future. We invest more that $50 million annually in healthcare R&D, allowing scientists at our company’s research centers around the world to advance healthcare innovation. At WHCC Burns showed a video that features two of the most interesting research projects we’re working on:
·Medication management: our researchers are developing “smart” medication packaging that will allow pharmacies to help patients manage their daily prescription regimen more easily. The system uses innovations in personalization, data collection and packaging to organize medication, provide individualized instruction and then track whether a patient adheres to the doctor’s orders.
The federal government is on the cusp of leveling the playing field for healthtech startups. Health 2.0 events have shown an unprecedented wave of innovative healthtech startups have developed over the last few years. You can also see them at demo day events that Blueprint Health, Healthbox, Rock Health and StartUp Health host. However, the health sector may be the single most challenging arena for startups.




